Abstract
Alzheimers disease (AD) is the most common neurodegenerative disease associated with aging. One important pathologic feature of AD is the formation of extracellular senile plaques in the brain, whose major components are small peptides called β-amyloid (Aβ) that are derived from β-amyloid precursor protein (APP) through sequential cleavages by β-secretase and γ-secretase. Because of the critical role of Aβ in the pathogenesis of AD, unraveling the cellular and molecular events underlying APP/Aβ metabolism has been and remains, of paramount importance to AD research. In this article we will focus on the regulation of APP metabolism leading to Aβ generation. We will review current knowledge of the secretases (α-, β-, and γ- secretases) involved in APP processing and various molecular and cellular mechanisms underlying intracellular trafficking of APP, which is a highly regulated process and whose disturbance has direct impacts on the production of Aβ.
Keywords: Alzheimer's disease, β-amyloid, β-amyloid precursor protein, metabolism, α-secretase, β-secretase, γ-secretase, trafficking
Current Molecular Medicine
Title: Molecular and Cellular Mechanisms for Alzheimers Disease:Understanding APP Metabolism
Volume: 7 Issue: 7
Author(s): Yun-wu Zhang and Huaxi Xu
Affiliation:
Keywords: Alzheimer's disease, β-amyloid, β-amyloid precursor protein, metabolism, α-secretase, β-secretase, γ-secretase, trafficking
Abstract: Alzheimers disease (AD) is the most common neurodegenerative disease associated with aging. One important pathologic feature of AD is the formation of extracellular senile plaques in the brain, whose major components are small peptides called β-amyloid (Aβ) that are derived from β-amyloid precursor protein (APP) through sequential cleavages by β-secretase and γ-secretase. Because of the critical role of Aβ in the pathogenesis of AD, unraveling the cellular and molecular events underlying APP/Aβ metabolism has been and remains, of paramount importance to AD research. In this article we will focus on the regulation of APP metabolism leading to Aβ generation. We will review current knowledge of the secretases (α-, β-, and γ- secretases) involved in APP processing and various molecular and cellular mechanisms underlying intracellular trafficking of APP, which is a highly regulated process and whose disturbance has direct impacts on the production of Aβ.
Export Options
About this article
Cite this article as:
Zhang Yun-wu and Xu Huaxi, Molecular and Cellular Mechanisms for Alzheimers Disease:Understanding APP Metabolism, Current Molecular Medicine 2007; 7 (7) . https://dx.doi.org/10.2174/156652407782564462
DOI https://dx.doi.org/10.2174/156652407782564462 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer’s Disease Therapy
Current Topics in Medicinal Chemistry Inhibitors of the Chemokine Receptor CXCR4: Chemotherapy of AIDS, Metastatic Cancer, Leukemia and Rheumatoid Arthritis
Letters in Drug Design & Discovery Tetracyclines and Prion Infectivity
Infectious Disorders - Drug Targets Aryltetralin-type Lignan of Podophyllum: A Comprehensive Review
The Natural Products Journal Destroying RNA as a Therapeutic Approach
Current Medicinal Chemistry Alzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid
Current Alzheimer Research Rhodiola and salidroside in the treatment of metabolic disorders
Mini-Reviews in Medicinal Chemistry Garlic-Derived Allyl Sulfides in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Impact of Opioids on Cardiac Electrophysiology
Current Cardiology Reviews Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach
Current Drug Targets Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update
Recent Patents on CNS Drug Discovery (Discontinued) Structure-Function Relationships of Antimicrobial Peptides and Proteins with Respect to Contact Molecules on Pathogen Surfaces
Current Topics in Medicinal Chemistry New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics
Current Topics in Medicinal Chemistry Cancer Molecular Imaging: Radionuclide-Based Biomarkers of the Epidermal Growth Factor Receptor (EGFR)
Current Topics in Medicinal Chemistry Tau Therapeutic Strategies for the Treatment of Alzheimers Disease
Current Topics in Medicinal Chemistry The Urokinase Receptor Interactome
Current Pharmaceutical Design Colloidal Supramolecular Aggregates for Therapeutic Application in Neuromedicine
Current Medicinal Chemistry